BMJ 1998;317:668-671 ( 5 September )
Education and debate
Strategies for promoting judicious use of antibiotics by
doctors and patients
Edward A Belongia, senior
epidemiologist, a
Benjamin Schwartz, medical epidemiologist. b
a Epidemiology Research Centre, Marshfield
Clinic, Marshfield, WI, USA, b Respiratory Diseases Branch, Disease Control
and Prevention, 1600 Clifton Road, MS E-61, Atlanta, GA 30333, USA
Correspondence to: Dr Schwartz bxsl{at}cdc.gov
Recent antibiotic use is a well documented risk factor for
infection or colonisation with resistant pathogens.1-7
Despite this recognition, unnecessary antibiotic prescribing remains
common. In the United States more than a fifth of all antibiotic
prescriptions for children and adults are written for upper respiratory
tract infections or bronchitis, conditions that are almost always
viral.
8 9
Similar rates of unnecessary antibiotic use
have been described in Britain.10 These findings are
consistent with results from focus groups among doctors, in which
participants have estimated that 10% to 50% of outpatient antibiotic
prescriptions are unnecessary.11
Only limited data are available to evaluate whether reducing antibiotic
prescribing will reduce the spread of resistance. In Finland the
proportion of group A streptococcal infections resistant to macrolides
was nearly halved after a successful campaign to reduce the use of
macrolide antibiotics.12 A cross sectional survey in
Iceland found that carriage of penicillin resistant pneumococci was
strongly associated with both individual and community-wide levels of
antimicrobial use,13 and there is some evidence that an
intervention programme has decreased the proportion of pneumococcal infections caused by penicillin resistant strains.14
|
Summary points
Unnecessary antibiotic use for viral illness is common and has
led to increasing rates of antibiotic resistance among
Streptococcus pneumoniae and other community acquired
pathogens
Factors that contribute to antibiotic overuse include lack of
education, patients' expectations, past experience, and economic
incentives
Multifaceted interventions are needed to reduce unnecessary antibiotic
use; peer education and feedback on doctors' use of antibiotics can
promote behaviour change
Educational interventions for the public should include a public
relations campaign with simple messages, clinic based patient
education, and community outreach activities
Health organisations should develop policies to support judicious
antibiotic use and evaluate whether existing policies may
unintentionally promote overuse of antibiotics
|
 |
Factors contributing to overuse of antibiotics |
Achieving more judicious prescribing of antibiotics requires
(a) an understanding of the factors that promote overuse
and the barriers to change and (b) the implementation of
effective strategies for changing behaviour. Well targeted but
ineffective interventions and effective but poorly targeted strategies
are equally futile. Both the message and the media are key elements. Results of formative research in the United States suggest that four
major factors promote the overuse of antibiotics: lack of education,
prior experience, patients' expectations, and economics (table). Lack
of education applies to both providers and patients. Surveys of primary
care doctors show that many have inaccurate knowledge regarding the
need for antibiotics in patients with purulent
rhinitis,
15 16
and many family practitioners do not follow expert recommendations for diagnosis and management of pharyngitis.17
Patients' lack of knowledge and past experience contribute to
increased demand for antibiotics. Many patients have received antibiotics for viral respiratory illness, and these treatments were
perceived as effective because the infections were generally self
limiting. Patients with lower educational levels seem to have the
greatest misconceptions about antibiotic use and upper respiratory
infections.18-20
Whether real or perceived, patients' expectations for antibiotics
affect doctors' prescribing behaviour.
10 11
Years of prescribing or taking antibiotics for viral respiratory infections have
created a cycle of supply and demand, reinforcing behaviours that are
detrimental in an era of increasing antibiotic resistance. Breaking
this cycle will require educating the public that past practices are no
longer optimal and convincing doctors that a patient's satisfaction is
based more on communication than on prescription.21
Economic factors contributing to overprescription will vary
substantially by country, depending on the type of medical care system.
However, for providers, time pressures and the desire to maximise the
patient's satisfaction (and thereby also retain him or her as a
possible patient in the future), and for both providers and patients
the desire to avoid follow up visits, are probably universal.
Diagnostic uncertainty can also contribute to unnecessary antibiotic
use. Occasional diagnostic uncertainty is inevitable, but it should
occur infrequently when an appropriate clinical evaluation is performed
and the findings are interpreted accurately. This will reduce the
likelihood that a clinician will prescribe an antibiotic "just in
case" an infection is bacterial. Performing a throat culture for
pharyngitis and use of pneumatic otoscopy for diagnosing otitis media
are two evaluation techniques that can reduce diagnostic uncertainty.
Appropriate clinical evaluation, combined with good communication and
shared decision making, will minimise the risk of incorrect diagnosis,
patients' dissatisfaction, or other adverse outcome. Guidelines have
recently been published to help clinicians evaluate common respiratory
illnesses appropriately.22
 |
Strategies to reduce inappropriate use of antibiotic |
Among providers
Most doctors are aware that antibiotic resistance is an emerging
problem created largely by the overuse of
antibiotics.
16 23
This widespread awareness suggests that
providing information or education alone will be insufficient to change
their prescribing behaviour. Overcoming barriers to more judicious
prescribing will require development of materials to support change,
implementation of effective techniques to catalyse that change, and
development of supportive structures in healthcare organisations. Key
elements include evidence based recommendations for diagnosis and
treatment backed by professional societies; materials for patient
education; and information to facilitate provider-patient
communication. Materials developed by the US Centers for Disease
Control and Prevention in conjunction with other organisations are
listed in the box. Similar materials have also been developed by
healthcare organisations, health departments, and at academic
centres.
|
Materials available to support an intervention programme on
antibiotic use
Principles of judicious antibiotic use for paediatric
infections22
Academic sheets providing one page summaries of the
principles of antibiotic use
Posters for educating patients
Pamphlets for educating patients
Question and answer sheets for viral respiratory
diagnoses
A "prescription pad" including recommendations for
symptomatic treatment for patients with viral respiratory infections
A letter to childcare providers stating that the child
can return to day care without an antibiotic
These materials are available from the Center
for Disease Control and Prevention (tel: 00 1 404 639 4702)
|
Guidelines for managing otitis media with effusion are available from
the Agency for Health Care Policy and Research.24 The
Infectious Diseases Society of America has published guidelines for
diagnosing and managing pharyngitis25 and is developing other guidelines. A recent review has suggested that locally developed guidelines are more likely to be accepted and followed than those developed nationally without local input or recognition of local needs.26
Development of clinical practice guidelines must be supported by other
educational activities, as multifaceted interventions tend to be more
effective than single interventions.27 Formal continuing
medical education conferences and distribution of printed materials
have little impact on doctors' behaviour unless reinforced by other
strategies.
27 28
These and other activities, however, may
enhance the adoption of clinical practice guidelines if they are
actively promoted to clinicians and endorsed by "opinion leaders" in each community.
Many studies have shown that education at an individual or small group
level and peer education are effective strategies to change doctors'
antibiotic prescribing behaviour.29-33 Face to face
interactions are supported by the common practice of pharmaceutical companies sending out representatives to promote their products. The
effectiveness of peer education is enhanced when the message is
delivered or endorsed by local opinion leaders and is made relevant to
the doctor's own practice. Previous successful programmes have used
retired doctors29 and clinical pharmacists.30
Establishing credibility, defining clear objectives for behaviour
change, and repetition and reinforcement are all important for peer
education.31 In addition, clinicians must have the
opportunity to voice their own concerns and provide feedback.
Implementing peer education on a broad scale may be difficult and
expensive because of the need to identify, train, and support
sufficient educators. An alternative worth exploring is video
presentation of information. Although costs would be substantially
reduced, the ability to tailor discussion to each clinician's needs
would be lost.
Providing feedback to clinicians regarding their own antibiotic
prescribing practices has been a successful technique for achieving
behaviour change.34 Feedback can entail comparisons with
peers or with a standard or indicator. As with practice guidelines, feedback may be most effective when the system is developed with local
input, where clinicians accept the measures as important, fair, and
relevant to their own practices. The availability of prescribing data
may be a limiting factor in some healthcare systems.
New communications technologies such as the internet enhance the
potential to disseminate practice guidelines and provide feedback to
clinicians. Computer assisted decision support has been used
effectively to improve antibiotic prescribing in hospitals and could be
extended to outpatient settings.35 The willingness of a
busy practitioner to use computer support during consultations with
patients, however, has not been assessed.
A limitation of all intervention strategies is that some
providers will participate and others will not. Participation may be
enhanced in a single payer system (system of nationalised care where
all costs are paid from one source) or a managed care organisation, where incentives or sanctions can be provided. Convincing local opinion
leaders to change practices will result in eventual diffusion of the
changes throughout the community, leading to a change in the standard
of care. For this reason, identifying and educating opinion leaders as
a priority group would be effective, particularly if resources are
limited. Educating future healthcare providers about the importance of
judicious antibiotic use will have long term impact and is a useful
adjunct to strategies focused on current providers.
 |
"To write prescriptions is easy, but to come to an
understanding with people is hard"
36
|
Among patients and the public
A multifaceted approach is needed to increase the public's
understanding of antibiotic resistance and to change expectations about
use of antibiotics. The key elements should include a public relations
campaign, clinic based education, and community outreach activities.
Conducting a public relations campaign with paid advertising is an
effective but expensive strategy to change health related behaviour.
Educating the public about the difference between bacterial and viral
infections, and the potential risk of taking antibiotics, is more
complex than other health education messages because the risk to
benefit ratio is less clear. A successful public relations effort will
require expertise in marketing and communications. Some companies may
be willing to sponsor components of a public relations campaign as a
community service. In recent years the popular media have been
increasing their coverage of antibiotic resistance, and this can
enhance the impact of other public education efforts.
Educational interventions for patients and parents at outpatient
clinics must be an important component of a public education campaign.
Information provided during a medical consultation is immediately
relevant and is likely to be viewed as authoritative. Clinicians should
obtain information material compiled for patients or review the content
of their own material to ensure that messages about appropriate
antibiotic use are emphasised. Medical providers should also seek
opportunities for community partnerships to disseminate similar
messages widely. For example, educational information can be
disseminated through community organisations, schools, childcare
centres, and pharmacies. In the short term, patients are likely to
benefit from a reduction in unnecessary visits and therapy. In the long
term, it is likely that decreased rates of resistance will improve
health and cost outcomes.
|
Intervention strategies for judicious antibiotic use and
approaches to enhance effectiveness of such strategies
| Strategy |
Approaches to enhance effectiveness |
| Clinical practice guidelines |
Develop with local input; promote actively |
| Peer (or small group) education |
Recruit respected source as educator; clearly communicate objectives; encourage discussion and tailor to local practice; distribute supportive materials; repeat and reinforce messages |
|
Develop with local input; provide peer comparison or compare with standard or indicator |
|
Use as a component of a multifaceted programme; obtain support of opinion leaders and professional societies |
| Feedback |
Use as a component of a multifaceted programme; obtain support of opinion leaders and professional societies |
|
Deliver in varied settings using various media; avoid clutter use a few consistent clear messages; develop local partnerships |
| Direct mailing of information |
|
| Lectures and continuing medical education |
| Education of patients and the public |
|
|
 |
Policy support |
Interventions must be supported by national and local policies
that promote judicious antibiotic use. National goals should be
developed to reduce unnecessary use, and progress toward those goals
should be monitored. Where needed, databases should be established to
support feedback interventions and programme evaluation. Economic factors that may affect practices must be carefully considered and,
where necessary, modified. Antibiotic overuse may be an unintended consequence of quality assurance tools, such as surveys of patients' satisfaction or profiling rates of follow up visits. Support is also
needed to encourage appropriate diagnostic testing, even if this
represents a short term direct cost. Sponsorship of continuing education and requirements for professional licensure are other potential policy options.
 |
Acknowledgments |
Competing interests: None declared.
 |
References |
-
Radetsky MS, Istre GR, Johansen TL, Parmelee SW, Lauer BA, Wiesenthal AM, et al.
Multiply resistant pneumococcus causing meningitis: its epidemiology within a day-care centre.
Lancet
1981;
2:
771-773[Medline].
-
Pallares R, Gudiol F, Linares J, Ariza J, Rufi G, Murgui L, et al.
Risk factors and response to antibiotic therapy in adults with bacteremic pneumonia caused by penicillin-resistant pneumococci.
N Engl J Med
1987;
317((1):
18-22[Abstract].
-
Guillemot D, Carbon C, Balkau B, Geslin P, Lecoeur H, Vauzelle-Kervroedan F, et al.
Low dosage and long treatment duration of beta-lactam: Risk factors for carriage of penicillin-resistant Streptococcus pneumoniae.
JAMA
1998;
279:
365-370[Abstract/Free Full Text].
-
Tan TQ, Mason Jr EO, Kaplan SL.
Penicillin-resistant systemic pneumococcal infections in children: a retrospective case-control study.
Pediatrics
1993;
92:
761-767[Abstract/Free Full Text].
-
Clavo-Sanchez AS, Giron-Sanchez JA, Lopez-Prieto D, Canueto-Quintero J, Sanchez Porto A, Vergara-Campos A, et al.
Multivariate analysis of risk factors for infection due to penicillin-resistant and multidrug resistant Streptococcus pneumoniae: a multicenter study.
Clin Infect Dis
1997;
24:
1052-1059[Medline].
-
Fairchild MP, Ashton WS, Fischer GW.
Carriage of penicillin resistant pneumococci in a military population in Washington, DC: risk factors and correlation with clinical isolates.
Clin Infect Dis
1996;
22:
966-972[Medline].
-
Dowell SF, Schwartz BS.
Resistant pneumococci: protecting patients through judicious use of antibiotics.
Am Fam Phys
1997;
55:
1647-1654[Medline].
-
Nyquist AC, Gonzales R, Steiner JF, Sande MA.
Antibiotic prescribing for children with colds, upper respiratory tract infections, and bronchitis.
JAMA
1998;
279:
875-877[Abstract/Free Full Text].
-
Gonzales R, Steiner JF, Sande MA.
Antibiotic prescribing for adults with colds, upper respiratory tract infections, and bronchitis by ambulatory care physicians.
JAMA
1997;
278:
901-904[Abstract].
-
MacFarlane J, Holmes W, MacFarlane R, Britten N.
Influence of patients' expectations on antibiotic management of acute lower respiratory tract illness in general practice: questionnaire study.
BMJ
1997;
315:
1211-1214[Abstract/Free Full Text].
-
Schwartz B, Barden L, Dowell S, Lackey C.
Why doctors overprescribe antibiotics: results of focus group discussions with pediatricians (Ped) and family physicians (FP) and application to a resistance prevention campaign (abstract). Presented at the International Conference on Emerging Infectious Diseases, Atlanta, 1998.
Atlanta, GA: Centers for Disease Control and Prevention, 1998:66.
-
Seppala H, Klaukka T, Vuopio-Varkila I, Muotiala A, Helenius H, Lager K, et al.
The effect of changes in the consumption of macrolide antibiotics on erythromycin resistance in group A streptococci in Finland.
N Engl J Med
1998;
337:
441-446[Abstract/Free Full Text].
-
Arason V, Kristinsson K, Sigurdsson J, Stefánsdóttir G, Mölstad S, Gudmundsson S.
Do antimicrobials increase the carriage rate of penicillin-resistant pneumococci in children? Cross sectional prevalence study.
BMJ
1996;
313:
387-391[Abstract/Free Full Text].
-
Stephenson J.
Icelandic researchers are showing the way to bring down rates of antibiotic-resistant bacteria [news].
JAMA
1996;
275:
175[Medline].
-
Mainous AG, Hueston WJ, Eberlein C.
Colour of respiratory discharge and antibiotic use.
Lancet
1997;
350:
1077[Medline].
-
Schwartz RH, Freij BJ, Ziai M, Sheridan MJ.
Antimicrobial prescribing for acute purulent rhinitis in children: a survey of pediatricians and family practitioners.
Pediatr Infect Dis J
1997;
16:
185-190[Medline].
-
McIsaac WJ, Goel V.
Sore throat management practices of Canadian family physicians.
Fam Pract
1996;
14((1):
34-39[Abstract/Free Full Text].
-
Mainous AG, Zoorob RJ, Oler MJ, Haynes OM.
Patient knowledge of upper respiratory infections: implications for antibiotic expectations and unnecessary utilization.
J Fam Pract
1997;
45((1):
75-83[Medline].
-
Chan CS.
What do patients expect from consultations for upper respiratory tract infections?
Fam Pract
1996;
13:
229-235[Abstract/Free Full Text].
-
Trepka MJ, Belongia CA, Davis JP.
Knowledge, attitudes and practices of caregivers regarding antibiotic use for children's upper respiratory infections (abstract). Presented at the International Conference on Emerging Infectious Diseases, Atlanta, 1998.
Atlanta, GA: Centers for Disease Control and Prevention, 1998:68.
-
Hamm RM, Hicks RJ, Bemben DA.
Antibiotics and respiratory infections: are patients more satisfied when expectations are met?
J Fam Pract
1996;
43:
56-62[Medline].
-
Dowell SF.
Principles of judicious use of antimicrobial agents for pediatric upper respiratory tract infections.
Pediatrics
1998;
101(suppl 1):
163-184[Abstract/Free Full Text].
-
Schwartz B, Bell DM, Hughes JM.
Preventing the emergence of antimicrobial resistance. A call for action by clinicians, public health officials, and patients.
JAMA
1997;
278:
944-945[Medline].
-
Otitis Media Guideline Panel.
Clinical practice guideline: otitis media with effusion in young children.
Rockville, MD: Agency for Health Care Policy and Research
, 1994(Report No 94-0622.)
-
Bisno AL, Gerber MA, Gwaltney JM, Kaplan AL, Schwartz RH.
Diagnosis and management of group A streptococcal pharyngitis: a practice guideline.
Clin Infect Dis
1997;
25:
574-583[Medline].
-
Grimshaw JM, Russell IT.
Effect of clinical guidelines on medical practice: a systematic review of rigorous evaluations.
Lancet
1993;
342:
317-322[Medline].
-
Davis DA, Thomson MA, Oxmen AD, Haynes RB.
Changing physician performance: a systematic review of the effect of continuing medical education strategies.
JAMA
1995;
274:
700-705[Abstract].
-
Soumerai S, McLaughlin T, Avorn J.
Improving drug prescribing in primary care: a critical analysis of the experimental literature.
Milbank Q
1989;
67:
268-317[Medline].
-
Schaffner W, Ray W, Federspiel C, Miller W.
Improving antibiotic prescribing in office practice.
JAMA
1983;
250:
1728-1732[Abstract].
-
Avorn J, Soumerai S.
Improving drug-therapy decisions through educational outreach.
N Engl J Med
1983;
308:
1457-1463[Abstract].
-
Soumerai S, Avorn J.
Principles of educational outreach ("academic detailing") to improve clinical decision making.
JAMA
1990;
263:
549-556[Abstract].
-
De Santis G, Harvey K, Howard D, Mashford M, Moulds R.
Improving the quality of antibiotic prescription patterns in general practice.
Med J Aust
1994;
160:
502-505[Medline].
-
Ekedahl A, Andersson S, Hovelius B, Molstad S, Liodholm H, Melandor A.
Drug prescription attitudes and behaviour of general practitioners. Effects of a problem oriented educational programme.
Eur J Clin Pharmacol
1995;
47:
381-387[Medline].
-
Schoenbaum SC.
Feedback of clinical practice information.
HMO Pract
1993;
7:
5-11[Medline].
-
Evans RS, Pestotnik SL, Classen DC, Clemmer TP, Weaver LK, Orme JF, et al.
A computer-assisted management program for antibiotics and other antiinfective agents.
N Engl J Med
1998;
338:
232-238[Abstract/Free Full Text].
-
Kafka F.
A country doctor. Selected short stories.
New York: Modern Linguists
, 1952.
© BMJ 1998